Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment

Mitotane is used as a post-operative adjuvant treatment for patients with adrenocortical carcinoma. Monitoring of plasma mitotane concentrations is recommended, but we do not know what impact target concentrations have on patient outcome. To answer this question, we retrospectively analyzed patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Puglisi, Soraya, Calabrese, Anna, Basile, Vittoria, Ceccato, Filippo, Scaroni, Carla, Simeoli, Chiara, Torlontano, Massimo, Cannavò, Salvatore, Arnaldi, Giorgio, Stigliano, Antonio, Malandrino, Pasqualino, Saba, Laura, Altieri, Barbara, Della Casa, Silvia, Perotti, Paola, Berchialla, Paola, De Filpo, Giuseppina, Canu, Letizia, Loli, Paola, Reimondo, Giuseppe, Terzolo, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912753/
https://www.ncbi.nlm.nih.gov/pubmed/31684071
http://dx.doi.org/10.3390/jcm8111850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912753/
https://www.ncbi.nlm.nih.gov/pubmed/31684071
http://dx.doi.org/10.3390/jcm8111850

Ejemplares similares